Research Article

Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism

Figure 4

PRDX6 deficiency induces hepatic steatosis on HFD. (a) Measurement of cholesterol, triglycerides, VLDL, HDL, ALT, and AST. Following 24 weeks on HFD, fasting serum samples in WT (black bar) and PRDX6-/- mice (white bar) were taken ( mice per group). (b) Microscopic analysis of the liver section in WT and PRDX6-/- mice upon HFD for 24 weeks. The images are shown at 20x magnification. (c) Steatosis score valuation in WT (black bar) and PRDX6-/- mice (white bar) ( mice per group). mRNA expression of genes involved in (d) lipid biogenesis (SREBP1-c, FAS, and CD36) and (e) lipolysis and β-oxidation (PNPLA2, Acox-1, and Cpt1-α). The results are expressed as . Statistically significant differences between PRDX6-/- mice and WT mice are indicated; and .
(a)
(b)
(c)
(d)
(e)